ARTICLE | Clinical News
Alista alprostadil: Phase IIb data
October 2, 2006 7:00 AM UTC
Data from the double-blind, placebo-controlled, U.S. Phase IIb trial in 320 women with FSAD, who have undergone hysterectomy, showed that Alista missed the primary endpoint of a significant improvemen...